Javier Fernández ^{Ultimate Decision-Maker}

Operating Partner at Columbus Venture Partners

Current Job Duration: 1 yr 2 mos (until March 2026)

HEADLINE:
Partner at Columbus Venture Partners

PERSONAL SUMMARY:
Currently:
-Board Member at Vitro S.A.
-Owner of Inversiones Bioavance SLU
-Operating Partner at Columbus Venture Partners SGIC SA
-Investment Committee Member at BuenaVista Equity Partners Healthcare Growth Fund
-Co-founder of Highlight Therapeutics SL (Valencia, Spain), CNIO's first spin-off
-Co-founder of Artax Biopharmaceuticals Llc (Boston, USA)

Past experience:

-Professor of Entrepreneurship, EMBA. IE Business School
-Faculty member at M+Vision Consortium, a biomedical imaging consortium funded by the Madrid Region (CAM) and managed by the Massachusetts Institute of Technology, MIT (Cambridge, USA)

-Co-founder and former Managing Partner (2006-2008) of Suanfarma Biotech SGECR (Spanish 1st VC fund specialised in biotechnology to be approved by Spain's CNMV). Responsible for arranging seed rounds in 3P, Halotech, Vivia Biotech, Pevesa and ClaveSuan SL and then working as Board Director.

-International Partner of Scientifica SAS (Bogotá, Colombia), working as an international expert in finance and entrepreneurship

-Non Executive Director at Angel Biotechnology Holdings Plc (UK), 2004-2008, a company sucessfully floated at London's AIM in 2005.
-Area Manager at Suanfarma SA. International trading of pharmaceutical raw materials and finished drugs.

Specialties: Venture capital, biotech start-ups, international business development, development of new biotech&medtech technologies

Languages: English, French

EDUCATION:
School: IE Business School
Degree: Executive MBA
Activities: None

School: Universidad Pontificia Comillas
Degree: ICADE (E-2), Bs in Business Administration (E2)
Activities: None

Number of Followers:
804